Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.6000 (-1.43%) ($8.6000 - $8.6000) on Fri. Jan. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 69 | Latest Price | $8.6000(-1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.415% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $8.88(-3.15%) | 10 Day Moving Average | $8.97(-4.12%) | 20 Day Moving Average | $8.4(2.38%) | To recent high | -7% | To recent low | 70.8% | Market Cap | $1.517b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |